You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Amneal Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for AMNEAL PHARMS, and what generic and branded alternatives to AMNEAL PHARMS drugs are available?

AMNEAL PHARMS has two hundred and seventeen approved drugs.

There are five tentative approvals on AMNEAL PHARMS drugs.

Summary for Amneal Pharms

US Patents:	0
Tradenames:	169
Ingredients:	164
NDAs:	217

Drugs and US Patents for Amneal Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Amneal Pharms	MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE	donepezil hydrochloride; memantine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	208328-001	Jan 27, 2017		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Amneal Pharms Co	DOXEPIN HYDROCHLORIDE	doxepin hydrochloride	CAPSULE;ORAL	207482-004	Jun 28, 2017	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Amneal Pharms	CARBAMAZEPINE	carbamazepine	TABLET, EXTENDED RELEASE;ORAL	212704-002	Sep 22, 2023		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Amneal Pharms Ny	GABAPENTIN	gabapentin	CAPSULE;ORAL	078428-003	Jul 25, 2007	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Amneal Pharms	NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)	nitrofurantoin; nitrofurantoin, macrocrystalline	CAPSULE;ORAL	207372-001	May 15, 2017	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Amneal Pharms Ny	IBUPROFEN	ibuprofen	TABLET;ORAL	071335-001	Nov 25, 1986	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Amneal Pharms Co	ERYTHROMYCIN	erythromycin	TABLET, DELAYED RELEASE;ORAL	210954-002	Jul 2, 2019	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for AMNEAL PHARMS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Injection	100 mg/mL, 2.5 mL vials	➤ Subscribe	2007-09-24
➤ Subscribe	Injection	1 mg/mL, 50 mL vials	➤ Subscribe	2011-12-16

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.